Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Winterfeld

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Swiss Medical Weekly|January 10, 2021
Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims dataJulia Spoendlin, Eva Blozik, Sereina Graber, et al.
Respiration; International Review of Thoracic Diseases|March 5, 2016
Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis PatientsAlice Panchaud, Ermindo R Di Paolo, Angela Koutsokera, et al.
Therapie|February 21, 2023
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION projectEvelina Cardoso, Anaëlle Monfort, Ema Ferreira, et al.
Swiss Medical Weekly|September 21, 2021
Impact of the COVID-19 pandemic on Swiss pregnant and breastfeeding women - a cross-sectional study covering the first pandemic waveValentine Lambelet, Michael Ceulemans, Hedvig Nordeng, et al.
Viruses|August 28, 2021
Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on "Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. <i>Viruses</i> 2021, <i>13</i>, 1199"Sarah Stuckelberger, Guillaume Favre, Michael Ceulemans, et al.
Revue Medicale Suisse|October 18, 2023
[Risk assessment of drugs during breastfeeding]Evelina Cardoso, Anaëlle Monfort, Ema Ferreira, et al.
BMC Pregnancy and Childbirth|April 16, 2025
Risk of adverse obstetrical and neonatal outcomes in women consuming recreational drugs during pregnancySreemanjari Kandhasamy, Karine Lepigeon, Stéphanie Baggio, et al.
Scientific Reports|November 3, 2022
Mental health in pregnant individuals during the COVID-19 pandemic based on a Swiss online surveyGuillaume Favre, Cléa Kunz, Simone Schwank, et al.
Viruses|July 2, 2021
SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in SwitzerlandSarah Stuckelberger, Guillaume Favre, Michael Ceulemans, et al.
Frontiers in Drug Safety and Regulation|November 7, 2025
Communicating medication risks in pregnancy: Towards shared decision makingUrsula Winterfeld, Kenneth Hodson, Maya Berlin, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Swiss Medical Weekly|January 10, 2021
Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims dataJulia Spoendlin, Eva Blozik, Sereina Graber, et al.
Respiration; International Review of Thoracic Diseases|March 5, 2016
Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis PatientsAlice Panchaud, Ermindo R Di Paolo, Angela Koutsokera, et al.
Therapie|February 21, 2023
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION projectEvelina Cardoso, Anaëlle Monfort, Ema Ferreira, et al.
Swiss Medical Weekly|September 21, 2021
Impact of the COVID-19 pandemic on Swiss pregnant and breastfeeding women - a cross-sectional study covering the first pandemic waveValentine Lambelet, Michael Ceulemans, Hedvig Nordeng, et al.
Viruses|August 28, 2021
Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on "Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. <i>Viruses</i> 2021, <i>13</i>, 1199"Sarah Stuckelberger, Guillaume Favre, Michael Ceulemans, et al.
Revue Medicale Suisse|October 18, 2023
[Risk assessment of drugs during breastfeeding]Evelina Cardoso, Anaëlle Monfort, Ema Ferreira, et al.
BMC Pregnancy and Childbirth|April 16, 2025
Risk of adverse obstetrical and neonatal outcomes in women consuming recreational drugs during pregnancySreemanjari Kandhasamy, Karine Lepigeon, Stéphanie Baggio, et al.
Scientific Reports|November 3, 2022
Mental health in pregnant individuals during the COVID-19 pandemic based on a Swiss online surveyGuillaume Favre, Cléa Kunz, Simone Schwank, et al.
Viruses|July 2, 2021
SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in SwitzerlandSarah Stuckelberger, Guillaume Favre, Michael Ceulemans, et al.
Frontiers in Drug Safety and Regulation|November 7, 2025
Communicating medication risks in pregnancy: Towards shared decision makingUrsula Winterfeld, Kenneth Hodson, Maya Berlin, et al.
Pageof 7